Farge D, Chatellier G, Pagny J Y, Jeunemaitre X, Plouin P F, Corvol P
Service d'Hypertension Artérielle Hôpital Broussais, Paris, France.
Am J Med. 1987 Oct;83(4):635-40. doi: 10.1016/0002-9343(87)90891-6.
Adrenocortical carcinoma is a rare disorder that can be revealed by an isolated syndrome of mineralocorticoid excess. In a retrospective study of 137 patients referred to our hypertension clinic in the past 10 years for primary aldosteronism, four cases of adrenocortical carcinoma were identified. The clinical presentation of these patients was similar to that of patients with Conn's adenoma, but preoperatively, malignant tumoral primary aldosteronism was suspected because of profound hypokalemia, marked elevation in plasma aldosterone levels, and enlarged size and weight of an heterogenous adrenal tumor with internal calcifications. Malignancy was confirmed by the histologic features. No prognostic criteria could be established and two patients died despite specific surgery, which was performed in all cases. More recent developments in the use of mitotane led to the addition of adrenocorticolytic therapy in the remaining two patients, who are still alive at the time of this report.
肾上腺皮质癌是一种罕见的疾病,可由单纯的盐皮质激素过多综合征揭示。在过去10年转诊至我们高血压诊所的137例原发性醛固酮增多症患者的回顾性研究中,确诊了4例肾上腺皮质癌。这些患者的临床表现与Conn腺瘤患者相似,但术前因严重低钾血症、血浆醛固酮水平显著升高、肾上腺肿瘤大小和重量增加且内部有钙化,怀疑为恶性肿瘤性原发性醛固酮增多症。通过组织学特征确诊为恶性。无法确立预后标准,尽管所有病例均进行了特定手术,但仍有2例患者死亡。米托坦使用的最新进展使其余2例患者接受了肾上腺皮质溶解疗法,在本报告撰写时这2例患者仍存活。